189 related articles for article (PubMed ID: 989135)
1. Failure of vancomycin treatment in Staphylococcus aureus endocarditis. In vivo and in vitro observations.
Gopal V; Bisno AL; Silverblatt FJ
JAMA; 1976 Oct; 236(14):1604-6. PubMed ID: 989135
[TBL] [Abstract][Full Text] [Related]
2. [Right endocarditis caused by Staphylococcus aureus in parenteral drug addicts: evaluation of a combined therapeutic scheme for 2 weeks versus conventional treatment].
Espinosa FJ; Valdés M; Martín-Luengo F; Arribas JP; Albaladejo J; Pérez-Gracia A; García-Henarejos JA; Martínez-Madrid O; García-Alberola A
Enferm Infecc Microbiol Clin; 1993 May; 11(5):235-40. PubMed ID: 8324018
[TBL] [Abstract][Full Text] [Related]
3. Combination antibiotic therapy in staphylococcal endocarditis. The use of methicillin sodium-gentamicin sulfate therapy.
Murray HW; Wigley FM; Mann JJ; Arthur RR
Arch Intern Med; 1976 Apr; 136(4):480-3. PubMed ID: 1267557
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of fosfomycin + vancomycin or gentamicin in experimental endocarditis due to methicillin-resistant Staphylococcus aureus (MRSA).
Olay T; Vicente MV; Rodríguez A
J Chemother; 1989 Jul; 1(4 Suppl):391-2. PubMed ID: 16312454
[No Abstract] [Full Text] [Related]
5. Staphylococcus aureus endocarditis. Combined therapy with vancomycin and rifampin.
Faville RJ; Zaske DE; Kaplan EL; Crossley K; Sabath LD; Quie PG
JAMA; 1978 Oct; 240(18):1963-5. PubMed ID: 249793
[TBL] [Abstract][Full Text] [Related]
6. Nafcillin-gentamicin synergism in experimental staphylococcal endocarditis.
Sande MA; Courtney KB
J Lab Clin Med; 1976 Jul; 88(1):118-24. PubMed ID: 1047088
[TBL] [Abstract][Full Text] [Related]
7. Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic.
Cosgrove SE; Vigliani GA; Fowler VG; Abrutyn E; Corey GR; Levine DP; Rupp ME; Chambers HF; Karchmer AW; Boucher HW
Clin Infect Dis; 2009 Mar; 48(6):713-21. PubMed ID: 19207079
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of vancomycin plus rifampin in experimental aortic-valve endocarditis due to methicillin-resistant Staphylococcus aureus: in vitro-in vivo correlations.
Bayer AS; Lam K
J Infect Dis; 1985 Jan; 151(1):157-65. PubMed ID: 3965588
[TBL] [Abstract][Full Text] [Related]
9. Teicoplanin compared with vancomycin for treatment of experimental endocarditis due to methicillin-resistant Staphylococcus epidermidis.
Galetto DW; Boscia JA; Kobasa WD; Kaye D
J Infect Dis; 1986 Jul; 154(1):69-75. PubMed ID: 2940303
[TBL] [Abstract][Full Text] [Related]
10. [Teicoplanin versus cloxacillin, cloxacillin-gentamycin and vancomycin in the treatment of experimental endocarditis caused by methicillin-sensitive Staphylococcus aureus].
Apellaniz G; Valdés M; Pérez R; Martín-Luengo F; García A; Soria F; Gómez J
Enferm Infecc Microbiol Clin; 1991 Apr; 9(4):208-10. PubMed ID: 1830757
[TBL] [Abstract][Full Text] [Related]
11. Therapy for experimental endocarditis due to Staphylococcus epidermidis.
Kobasa WD; Kaye KL; Shapiro T; Kaye D
Rev Infect Dis; 1983; 5 Suppl 3():S533-7. PubMed ID: 6635444
[TBL] [Abstract][Full Text] [Related]
12. Failure of once-daily vancomycin for staphylococcal endocarditis.
Marik PE
Pharmacotherapy; 1998; 18(3):650-2. PubMed ID: 9620118
[TBL] [Abstract][Full Text] [Related]
13. Ciprofloxacin therapy of experimental endocarditis caused by methicillin-susceptible or methicillin-resistant Staphylococcus aureus.
Fernandez-Guerrero M; Rouse M; Henry N; Wilson W
Antimicrob Agents Chemother; 1988 May; 32(5):747-51. PubMed ID: 3164989
[TBL] [Abstract][Full Text] [Related]
14. Bactericidal activity of oxacillin and glycopeptides against Staphylococcus aureus in patients with endocarditis: looking for a relationship between tolerance and outcome.
Pasticci MB; Moretti A; Stagni G; Ravasio V; Soavi L; Raglio A; Vailati F; Cardaccia A; Santucci A; Papili R; Sgrelli A; Pallotto C; Baldelli F
Ann Clin Microbiol Antimicrob; 2011 Jun; 10():26. PubMed ID: 21658248
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of ceftobiprole in a rabbit model of aortic valve endocarditis due to methicillin-resistant and vancomycin-intermediate Staphylococcus aureus.
Chambers HF
Antimicrob Agents Chemother; 2005 Mar; 49(3):884-8. PubMed ID: 15728879
[TBL] [Abstract][Full Text] [Related]
16. Cost-Effectiveness of daptomycin versus vancomycin and gentamicin for patients with methicillin-resistant Staphylococcus aureus bacteremia and/or endocarditis.
Bhavnani SM; Prakhya A; Hammel JP; Ambrose PG
Clin Infect Dis; 2009 Sep; 49(5):691-8. PubMed ID: 19635023
[TBL] [Abstract][Full Text] [Related]
17. Gentamicin may have no effect on mortality of staphylococcal prosthetic valve endocarditis.
Ramos-Martínez A; Muñoz Serrano A; de Alarcón González A; Muñoz P; Fernández-Cruz A; Valerio M; Fariñas MC; Gutiérrez-Cuadra M; Miró JM; Ruiz-Morales J; Sousa-Regueiro D; Montejo JM; Gálvez-Acebal J; HidalgoTenorio C; Domínguez F;
J Infect Chemother; 2018 Jul; 24(7):555-562. PubMed ID: 29628387
[TBL] [Abstract][Full Text] [Related]
18. Endocarditis due to streptomycin-susceptible Enterococcus faecalis with high-level gentamicin resistance.
Spiegel CA; Huycke M
Arch Intern Med; 1989 Aug; 149(8):1873-5. PubMed ID: 2504123
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial therapy of experimental endocarditis caused by Staphylococcus aureus.
Sande MA; Johnson ML
J Infect Dis; 1975 Apr; 131(4):367-75. PubMed ID: 1117194
[TBL] [Abstract][Full Text] [Related]
20. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus.
Fowler VG; Boucher HW; Corey GR; Abrutyn E; Karchmer AW; Rupp ME; Levine DP; Chambers HF; Tally FP; Vigliani GA; Cabell CH; Link AS; DeMeyer I; Filler SG; Zervos M; Cook P; Parsonnet J; Bernstein JM; Price CS; Forrest GN; Fätkenheuer G; Gareca M; Rehm SJ; Brodt HR; Tice A; Cosgrove SE;
N Engl J Med; 2006 Aug; 355(7):653-65. PubMed ID: 16914701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
